SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-14-375108
Filing Date
2014-10-17
Accepted
2014-10-17 16:49:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d805914dsc14d9.htm SC 14D9 437201
2 EX-99.(A)(9) d805914dex99a9.htm EX-99.(A)(9) 4366
3 GRAPHIC g805914g28f54.jpg GRAPHIC 11864
4 GRAPHIC g805914g65j72.jpg GRAPHIC 8696
  Complete submission text file 0001193125-14-375108.txt   471798
Mailing Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606 312-219-7000
Durata Therapeutics, Inc. (Filed by) CIK: 0001544116 (see all company filings)

IRS No.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606 312-219-7000
Durata Therapeutics, Inc. (Subject) CIK: 0001544116 (see all company filings)

IRS No.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-86923 | Film No.: 141162307
SIC: 2834 Pharmaceutical Preparations